GlaxoSmithKline S.A.E
CASE:BIOC
£ 28.91
£-0.10 (-0.34%)
£ 28.91
£-0.10 (-0.34%)
End-of-day quote: 05/22/2024

BIOC: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
NYSE:LLY
Eli Lilly and
802.91 -50.83% -30.66% 722,944.49 0.65% 2.63%
CPSE:NOVO B
Novo Nordisk A/S
923.00 -27.81% -12.5% 4,094,574.01 1.01% 18.5%
NYSE:ABBV
AbbVie
159.61 -19.77% -9.16% 281,850.16 3.81% 7.03%
LSE:AZN
AstraZeneca PLC
123.60 16.48% 38.75% 191,609.05 1.97% 15.98%
SWX:ROG
Roche Holding
231.90 28.15% 43.79% 187,387.65 4.1% 0.43%
NSEI:PFIZER
Pfizer
4494.95 15.65% 22.69% 204,631.89 0.78% 4.92%